These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10573088)

  • 1. Intragraft overexpression of interleukin-4 is neither sufficient nor essential for tolerance induction to cardiac allografts in a high-responder strain combination.
    Ritter T; Risch K; Schroder G; Kolls J; Siegling A; Graser E; Reinke P; Brock J; Lehmann M; Volk HD
    Transplantation; 1999 Nov; 68(9):1427-31. PubMed ID: 10573088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predominant expression of T helper 2 cytokines and altered expression of T helper 1 cytokines in long-term allograft survival induced by intrathymic immune modulation with donor class I major histocompatibility complex peptides.
    Shirwan H; Barwari L; Khan NS
    Transplantation; 1998 Dec; 66(12):1802-9. PubMed ID: 9884279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts.
    Binder J; Lehmann M; Graser E; Hancock WW; Watschinger B; Onodera K; Sayegh MH; Volk HD; Kupiec-Weglinski JW
    Transplantation; 1996 Mar; 61(5):804-11. PubMed ID: 8607187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-CD4 monoclonal antibody-induced tolerance to MHC-incompatible cardiac allografts maintained by CD4+ suppressor T cells that are not dependent upon IL-4.
    Hall BM; Fava L; Chen J; Plain KM; Boyd RA; Spicer ST; Berger MF
    J Immunol; 1998 Nov; 161(10):5147-56. PubMed ID: 9820484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory cells potentiate the efficacy of IL-4 gene transfer by up-regulating Th2-dependent expression of protective molecules in the infectious tolerance pathway in transplant recipients.
    Ke B; Ritter T; Kato H; Zhai Y; Li J; Lehmann M; Busuttil RW; Volk HD; Kupiec-Weglinski JW
    J Immunol; 2000 Jun; 164(11):5739-45. PubMed ID: 10820251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-CD4 monoclonal antibody-induced allograft tolerance in rats despite persistence of donor-reactive T cells.
    Lehmann M; Graser E; Risch K; Hancock WW; Müller A; Kuttler B; Hahn HJ; Kupiec-Weglinski JW; Brock J; Volk HD
    Transplantation; 1997 Oct; 64(8):1181-7. PubMed ID: 9355837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen.
    Arima T; Lehmann M; Flye MW
    Transplantation; 1997 Jan; 63(2):284-92. PubMed ID: 9020332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymus-dependent, anti-CD4-induced tolerance to rat cardiac allografts.
    Jaques BC; Ahmiedat H; Alastair Gracie J; Marshall HE; Middleton SE; Bolton EM; Bradley JA
    Transplantation; 1998 Nov; 66(10):1291-9. PubMed ID: 9846511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with interleukin-4 prolongs allogeneic neonatal heart graft survival by inducing T helper 2 responses.
    He XY; Chen J; Verma N; Plain K; Tran G; Hall BM
    Transplantation; 1998 May; 65(9):1145-52. PubMed ID: 9603159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term allograft acceptance induced by single dose anti-leukocyte common antigen (RT7) antibody in the rat.
    Ko S; Jager MD; Tsui TY; Deiwick A; Dinkel A; Rohde F; Dahlke MH; Lauth O; Wonigeit K; Schlitt HJ
    Transplantation; 2001 Apr; 71(8):1124-31. PubMed ID: 11374414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The kinetics of tolerance induction by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus intravenous donor alloantigen administration.
    Motoyama K; Arima T; Yu S; Lehmann M; Flye MW
    Transplantation; 2000 Jan; 69(2):285-93. PubMed ID: 10670640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of specific tolerance to allografts in rats by therapy with non-mitogenic, non-depleting anti-CD3 monoclonal antibody: association with TH2 cytokines not anergy.
    Plain KM; Chen J; Merten S; He XY; Hall BM
    Transplantation; 1999 Feb; 67(4):605-13. PubMed ID: 10071035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of acquired thymic tolerance induced by a single major histocompatibility complex class I peptide with the dominant epitope: differential analysis of regulatory cytokines in the lymphoid and intragraft compartments.
    Oluwole SF; Chowdhury NC; Ingram M; Garrovillo M; Jin MX; Agrawal S
    Transplantation; 1999 Aug; 68(3):418-29. PubMed ID: 10459547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation.
    Hancock WW; Sayegh MH; Kwok CA; Weiner HL; Carpenter CB
    Transplantation; 1993 May; 55(5):1112-8. PubMed ID: 8497891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-CD25 monoclonal antibody modulates cytokine expression and prolongs allografts survival in rats cardiac transplantation.
    Xia J; Jiang X; Huang Y; Zhang K; Xiao S; Yang C
    Chin Med J (Engl); 2003 Mar; 116(3):432-5. PubMed ID: 12781053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation.
    Guo L; Fujino M; Kimura H; Funeshima N; Kitazawa Y; Harihara Y; Tezuka K; Makuuchi M; Suzuki S; Li XK
    Transpl Immunol; 2003; 12(1):41-8. PubMed ID: 14551031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response after adenoviral gene transfer in syngeneic heart transplants: effects of anti-CD4 monoclonal antibody therapy.
    Schröder G; Risch K; Nizze H; Kolls J; Reinke P; Brock J; Lehmann M; Volk HD; Ritter T
    Transplantation; 2000 Jul; 70(1):191-8. PubMed ID: 10919599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking of mononuclear cell accumulation, cytokine production, and endothelial activation within rat cardiac allografts by CD4 monoclonal antibody therapy.
    Hancock WW; Sayegh MH; Sablinski T; Kut JP; Kupiec-Weglinski JW; Milford EL
    Transplantation; 1992 Jun; 53(6):1276-80. PubMed ID: 1604485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplant tolerance associated with a Th1 response and not broken by IL-4, IL-5, and TGF-beta blockade or Th1 cytokine administration.
    Plain KM; Boyd R; Verma ND; Robinson CM; Tran GT; Hodgkinson SJ; Hall BM
    Transplantation; 2007 Mar; 83(6):764-73. PubMed ID: 17414711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.